REIT - Specialty
Compare Stocks
2 / 10Stock Comparison
CXW vs ADUS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
CXW vs ADUS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Specialty | Medical - Care Facilities |
| Market Cap | $2.16B | $1.81B |
| Revenue (TTM) | $2.34B | $1.45B |
| Net Income (TTM) | $129M | $100M |
| Gross Margin | 23.6% | 32.5% |
| Operating Margin | 14.7% | 9.8% |
| Forward P/E | 14.4x | 14.1x |
| Total Debt | $1.22B | $209M |
| Cash & Equiv. | $112M | $82M |
CXW vs ADUS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CoreCivic, Inc. (CXW) | 100 | 181.3 | +81.3% |
| Addus HomeCare Corp… (ADUS) | 100 | 98.3 | -1.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CXW vs ADUS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CXW is the clearest fit if your priority is momentum.
- -3.5% vs ADUS's -13.4%
ADUS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.58
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- 399.9% 10Y total return vs CXW's -13.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.2% revenue growth vs CXW's 12.7% | |
| Value | Lower P/E (14.1x vs 14.4x), PEG 0.70 vs 0.75 | |
| Quality / Margins | 6.9% margin vs CXW's 5.5% | |
| Stability / Safety | Beta 0.58 vs CXW's 0.61, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -3.5% vs ADUS's -13.4% | |
| Efficiency (ROA) | 7.0% ROA vs CXW's 4.0%, ROIC 8.8% vs 10.7% |
CXW vs ADUS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CXW vs ADUS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — CXW and ADUS each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CXW is the larger business by revenue, generating $2.3B annually — 1.6x ADUS's $1.4B. Profitability is closely matched — net margins range from 6.9% (ADUS) to 5.5% (CXW). On growth, CXW holds the edge at +25.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.3B | $1.4B |
| EBITDAEarnings before interest/tax | $475M | $159M |
| Net IncomeAfter-tax profit | $129M | $100M |
| Free Cash FlowCash after capex | $49M | $137M |
| Gross MarginGross profit ÷ Revenue | +23.6% | +32.5% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +9.8% |
| Net MarginNet income ÷ Revenue | +5.5% | +6.9% |
| FCF MarginFCF ÷ Revenue | +2.1% | +9.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.8% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +56.5% | +17.2% |
Valuation Metrics
ADUS leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, ADUS trades at a 8% valuation discount to CXW's 20.2x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs CXW's 1.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.2B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $1.9B |
| Trailing P/EPrice ÷ TTM EPS | 20.19x | 18.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.44x | 14.12x |
| PEG RatioP/E ÷ EPS growth rate | 1.06x | 0.93x |
| EV / EBITDAEnterprise value multiple | 6.83x | 12.52x |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 1.28x |
| Price / BookPrice ÷ Book value/share | 1.67x | 1.65x |
| Price / FCFMarket cap ÷ FCF | 39.96x | 17.48x |
Profitability & Efficiency
ADUS leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
ADUS delivers a 9.3% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $9 for CXW. ADUS carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to CXW's 0.87x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.0% | +9.3% |
| ROA (TTM)Return on assets | +4.0% | +7.0% |
| ROICReturn on invested capital | +10.7% | +8.8% |
| ROCEReturn on capital employed | +12.6% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.87x | 0.19x |
| Net DebtTotal debt minus cash | $1.1B | $127M |
| Cash & Equiv.Liquid assets | $112M | $82M |
| Total DebtShort + long-term debt | $1.2B | $209M |
| Interest CoverageEBIT ÷ Interest expense | 3.53x | 14.45x |
Total Returns (Dividends Reinvested)
CXW leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CXW five years ago would be worth $26,794 today (with dividends reinvested), compared to $10,002 for ADUS. Over the past 12 months, CXW leads with a -3.5% total return vs ADUS's -13.4%. The 3-year compound annual growth rate (CAGR) favors CXW at 33.0% vs ADUS's 5.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +14.7% | -8.7% |
| 1-Year ReturnPast 12 months | -3.5% | -13.4% |
| 3-Year ReturnCumulative with dividends | +135.0% | +16.3% |
| 5-Year ReturnCumulative with dividends | +167.9% | +0.0% |
| 10-Year ReturnCumulative with dividends | -13.4% | +399.9% |
| CAGR (3Y)Annualised 3-year return | +33.0% | +5.2% |
Risk & Volatility
Evenly matched — CXW and ADUS each lead in 1 of 2 comparable metrics.
Risk & Volatility
ADUS is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than CXW's 0.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CXW currently trades 92.7% from its 52-week high vs ADUS's 78.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.61x | 0.58x |
| 52-Week HighHighest price in past year | $23.54 | $124.44 |
| 52-Week LowLowest price in past year | $15.74 | $90.89 |
| % of 52W HighCurrent price vs 52-week peak | +92.7% | +78.2% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 49.3 |
| Avg Volume (50D)Average daily shares traded | 993K | 236K |
Analyst Outlook
ADUS leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CXW as "Buy" and ADUS as "Buy". Consensus price targets imply 32.3% upside for ADUS (target: $129) vs -28.9% for CXW (target: $16).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $15.50 | $128.67 |
| # AnalystsCovering analysts | 12 | 15 |
| Dividend YieldAnnual dividend ÷ price | +0.0% | — |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +10.6% | 0.0% |
ADUS leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). CXW leads in 1 (Total Returns). 2 tied.
CXW vs ADUS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CXW or ADUS a better buy right now?
For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.
2% revenue growth year-over-year, versus 12. 7% for CoreCivic, Inc. (CXW). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate CoreCivic, Inc. (CXW) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CXW or ADUS?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
7x versus CoreCivic, Inc. at 20. 2x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus CoreCivic, Inc. 's 0. 75x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CXW or ADUS?
Over the past 5 years, CoreCivic, Inc.
(CXW) delivered a total return of +167. 9%, compared to +0. 0% for Addus HomeCare Corporation (ADUS). Over 10 years, the gap is even starker: ADUS returned +399. 9% versus CXW's -13. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CXW or ADUS?
By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.
58β versus CoreCivic, Inc. 's 0. 61β — meaning CXW is approximately 6% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 87% for CoreCivic, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CXW or ADUS?
By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.
2% versus 12. 7% for CoreCivic, Inc. (CXW). On earnings-per-share growth, the picture is similar: CoreCivic, Inc. grew EPS 74. 2% year-over-year, compared to 23. 2% for Addus HomeCare Corporation. Over a 3-year CAGR, ADUS leads at 14. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CXW or ADUS?
Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.
7% net margin versus 5. 3% for CoreCivic, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CXW leads at 15. 8% versus 9. 7% for ADUS. At the gross margin level — before operating expenses — ADUS leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CXW or ADUS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus CoreCivic, Inc. 's 0. 75x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 1x forward P/E versus 14. 4x for CoreCivic, Inc. — 0. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 32. 3% to $128. 67.
08Which pays a better dividend — CXW or ADUS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CXW or ADUS better for a retirement portfolio?
For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
58), +399. 9% 10Y return). Both have compounded well over 10 years (ADUS: +399. 9%, CXW: -13. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CXW and ADUS?
These companies operate in different sectors (CXW (Real Estate) and ADUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CXW is a small-cap quality compounder stock; ADUS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.